📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Medipal Holdings Corp

Common Name

Medipal Holdings

Country

Japan

Sector

Healthcare

Industry

Medical Distribution

Employees

13,075

Ticker

7459

Exchange

TOKYO STOCK EXCHANGE

Website

www.medipal.co.jp

Description

Medipal Holdings Corp is a leading company in Japan's pharmaceutical distribution industry. As a comprehensive pharmaceutical wholesaler, its primary function is to ensure the efficient distribution a... Show more

Income Statement Balance Sheet Group Entities

Medipal Holdings's Financial Statements Preview

Below are the financial statements of Medipal Holdings, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of JPY	2025 as of 2025-03-31	2024 as of 2024-03-31
Assets	—	—
Current assets	—	—
Cash and deposits	261,407^a	230,154^a
Notes receivable – trade	14,455^a	15,432^a
Accounts receivable – trade	749,085^a	742,652^a
Securities	0^a	316^a
Merchandise and finished goods	178,100^a	172,030^a
Accounts receivable – other	66,826^a	66,516^a
Other	12,912^a	17,218^a
Allowance for doubtful accounts	-42^a	-129^a
Total current assets	1,282,746^a	1,244,190^a
Non-current assets	—	—
Property, plant and equipment	—	—
Buildings and structures, net	103,180^a	108,911^a
Machinery, equipment and vehicles, net	31,311^a	34,824^a
Land	117,285^a	117,324^a
Construction in progress	10,958^a	6,717^a
Other, net	5,829^a	3,174^a
Total property, plant and equipment	268,564^a	270,953^a
Intangible assets	—	—
Goodwill	13,150^a	11,625^a
Customer-related intangible assets	16,392^a	17,653^a
Software	8,440^a	8,042^a
Other	1,915^a	1,693^a
Total intangible assets	39,898^a	39,014^a
Investments and other assets	—	—
Investment securities	199,078^a	210,865^a
Long-term loans receivable	115^a	110^a
Deferred tax assets	4,890^a	5,431^a
Retirement benefit asset	9,722^a	9,749^a
Other	20,614^a	19,457^a
Allowance for doubtful accounts	-644^a	-645^a
Total investments and other assets	233,774^a	244,969^a
Total non-current assets	542,237^a	554,937^a
Total assets	1,824,984^a	1,799,127^a
Liabilities	—	—
Current liabilities	—	—
Notes and accounts payable – trade	932,474^a	924,297^a
Income taxes payable	13,329^a	13,630^a
Provision for bonuses	7,854^a	8,035^a
Provision for loss on disaster	0^a	453^a
Provision for loss on disposal of fixed assets	167^a	0^a
Provision for loss on Anti-Monopoly Act	2,233^a	5,704^a
Other	53,387^a	55,596^a
Total current liabilities	1,009,447^a	1,007,719^a
Non-current liabilities	—	—
Deferred tax liabilities	32,858^a	34,056^a
Deferred tax liabilities for land revaluation	813^a	825^a
Retirement benefit liability	16,057^a	16,583^a
Other	7,860^a	3,330^a
Total non-current liabilities	57,590^a	54,796^a
Total liabilities	1,067,037^a	1,062,515^a
Net assets	—	—
Shareholders’ equity	—	—
Share capital	22,398^a	22,398^a
Capital surplus	100,010^a	99,807^a
Retained earnings	463,071^a	439,315^a
Treasury shares	-22,193^a	-21,254^a
Total shareholders’ equity	563,286^a	540,265^a
Accumulated other comprehensive income	—	—
Valuation difference on available-for-sale securities	66,060^a	70,347^a
Deferred gains or losses on hedges	-37^a	-3^a
Revaluation reserve for land	-13,518^a	-13,415^a
Foreign currency translation adjustment	2,646^a	1,908^a
Remeasurements of defined benefit plans	1,126^a	1,246^a
Total accumulated other comprehensive income	56,277^a	60,083^a
Share acquisition rights	1^a	0^a
Non-controlling interests	138,381^a	136,263^a
Total net assets	757,947^a	736,612^a
Total liabilities and net assets	1,824,984^a	1,799,127^a

Verified Sources Behind Medipal Holdings’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medipal Holdings’s data sources below and access millions more through our Disclosure Search.

a. Medipal Holdings's Financial Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Medipal Holdings Corp

Medipal Holdings's Financial Statements Preview

Medipal Holdings's Financial Statements Preview

Verified Sources Behind Medipal Holdings’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Alfresa Holdings Corp

Cosmos Pharmaceutical Corp

Kyowa Kirin Co Ltd

Daiichi Sankyo Co Ltd

Astellas Pharma Inc

Sundrug Co Ltd